Movement Disorders (revue) - Curation (Ncbi)

Index « Keywords » - entrée « Antiparkinson Agents (pharmacology) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antiparkinson Agents (pharmacokinetics) < Antiparkinson Agents (pharmacology) < Antiparkinson Agents (standards)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 72.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000926 (2002) Marie-Paule Muriel [France] ; Gaël Orieux ; Etienne C. HirschLevodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats.
000A52 (2003) Lance A. Smith [Royaume-Uni] ; Michael J. Jackson ; Matthew J. Hansard ; Eleni Maratos ; Peter JennerEffect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administration, and brain exposure.
000A62 (2003) Blanka Hejduková [Suède] ; Nasser Hosseini ; Bo Johnels ; Pall E. Ingvarsson ; Göran Steg ; Torsten OlssonManual transport in Parkinson's disease.
000A63 (2003) Tomoyuki Uchiyama [Japon] ; Ryuji Sakakibara ; Takamichi Hattori ; Tomonori YamanishiShort-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon.
000C82 (2004) Matthew J. Hansard [Royaume-Uni] ; Lance A. Smith ; Michael J. Jackson ; Sharon C. Cheetham ; Peter JennerThe monoamine reuptake inhibitor BTS 74 398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primates.
001021 (2005) Paolo Lamberti [Italie] ; Stefano Zoccolella ; Giovanni Iliceto ; Elio Armenise ; Angela Fraddosio ; Michele De Mari ; Paolo LivreaEffects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients.
001471 (2006) Thomas Müller [Allemagne] ; Christoph Erdmann ; Siegfried Muhlack ; Dirk Bremen ; Horst Przuntek ; Dirk WoitallaInhibition of catechol-O-methyltransferase contributes to more stable levodopa plasma levels.
001843 (2006) Hatice Kumru [Espagne] ; Joan Santamaria ; Francesc Valldeoriola ; Maria J. Marti ; Eduardo TolosaIncrease in body weight after pramipexole treatment in Parkinson's disease.
001F90 (2008) Aileen K. Ho [Royaume-Uni] ; John L. Bradshaw ; Robert IansekFor better or worse: The effect of levodopa on speech in Parkinson's disease.
002149 (2008) Peter Valkovic ; Hana Brozová ; Kai Bötzel ; Evzen Růzicka ; Ján BenetinPush-and-release test predicts Parkinson fallers and nonfallers better than the pull test: comparison in OFF and ON medication states.
002308 (2008) John G. Nutt [États-Unis]Pharmacokinetics and pharmacodynamics of levodopa.
002359 (2009) Bettina Pollok [Allemagne] ; Houssain Makhloufi ; Markus Butz ; Joachim Gross ; Lars Timmermann ; Lars Wojtecki ; Alfons SchnitzlerLevodopa affects functional brain networks in Parkinsonian resting tremor.
002416 (2009) Nathalie Chastan [France] ; Manh Cuong Do ; Fabrice Bonneville ; Frédéric Torny ; Frédéric Bloch ; G W Max Westby ; Didier Dormont ; Yves Agid [France] ; Marie-Laure WelterGait and balance disorders in Parkinson's disease: impaired active braking of the fall of centre of gravity.
002528 (2009) Birgitta Loref Lt [Suède] ; Göran Toss ; Ann-Kathrine GranérusWeight loss, body fat mass, and leptin in Parkinson's disease.
002635 (2009) Jan Herzog [Allemagne] ; Bettina Möller ; Karsten Witt ; Marcus O. Pinsker ; Günther Deuschl ; Jens VolkmannInfluence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
002649 (2009) Elizabeth L. Stegemöller [États-Unis] ; Tanya Simuni [États-Unis] ; Colum Mackinnon [États-Unis]Effect of Movement Frequency on Repetitive Finger Movements in Patients with Parkinson's Disease
002705 (2009) Yumi Sakakibara [Japon] ; Masato Asahina ; Atsuya Suzuki ; Takamichi HattoriGastric myoelectrical differences between Parkinson's disease and multiple system atrophy.
002716 (2009) David Weise [Allemagne] ; Reinhard Lorenz ; Mira Schliesser ; Andreas Schirbel ; Karlheinz Reiners ; Joseph ClassenSubstantia nigra echogenicity: A structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease.
002719 (2009) Roberta Zangaglia [Italie] ; Claudio Pacchetti ; Chiara Pasotti ; Francesca Mancini ; Domenico Servello ; Elena Sinforiani ; Silvano Cristina ; Marco Sassi ; Giuseppe NappiDeep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study.
002728 (2009) Bruno Fimm [Allemagne] ; Ines A. Heber ; Volker A. Coenen ; Christoph Fromm ; Johannes Noth ; Martin KronenbuergerDeep brain stimulation of the subthalamic nucleus improves intrinsic alertness in Parkinson's disease.
002731 (2009) Jeffrey M. Hausdorff [Israël] ; Leor Gruendlinger ; Lisa Scollins ; Siobhan O'Herron ; Daniel TarsyDeep brain stimulation effects on gait variability in Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Antiparkinson Agents (pharmacology)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Antiparkinson Agents (pharmacology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiparkinson Agents (pharmacology)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024